Gottlieb Issues Statement On Adverse Event Limitations – An Attempt To Quell Fears?
Commissioner Scott Gottlieb's statement noting the limitations of FAERS comes just four days after he was quoted in an FDA announcement about the launch of a more searchable portal for the adverse event database.
You may also be interested in...
US FDA’s Precision Medicine Efforts Turn Towards Adverse Events
Next PrecisionFDA challenge aims to detect ‘adverse event anomalies’ including manufacturer-specific patterns and drug-drug interactions.
US FDA Data Strategy Will Cover Security For Internal Sharing
FDA seeks expert comments during an upcoming public meeting on strategies to facilitate various centers combining and sharing data.
US FDA's New Website May Facilitate Broader Outside Use Of Data
Redesigned FDA.gov is expected to allow application programming interfaces, which could allow other software to talk to the site and potentially use its data.